Skip to main content
. 2015 Aug 18;10(8):e0135441. doi: 10.1371/journal.pone.0135441

Fig 3. Consumption of anti-inflammatory/antipyretic drugs and its effects on FLS.

Fig 3

(A) Comparison of mean number (no.) of anti-inflammatory/antipyretic drugs taken during the follow-up by patients bearing at least one C allele at position -174 of IL-6 gene vs. those bearing two G alleles at the same position. (B) Comparison of mean FLS severity score in patients taking the first dose of anti-inflammatory/antipyretic drugs in the peri-injection period vs. those that assumed the first dose hours later. (C) Effect of the peri-injection dose of antipyretic/anti-inflammatory drug on the probability of developing FLS in patients taking different total doses of antipyretic/anti-inflammatory drugs.